pubmed.ncbi.nlm.nih.gov

Vasorelaxation and hyperpolarisation of rat small mesenteric artery by the quaternary anion tetraphenylboron - PubMed

Comparative Study

. 2004 Apr;369(4):367-73.

doi: 10.1007/s00210-004-0879-8. Epub 2004 Mar 19.

Affiliations

Comparative Study

Vasorelaxation and hyperpolarisation of rat small mesenteric artery by the quaternary anion tetraphenylboron

Joanne L Favaloro et al. Naunyn Schmiedebergs Arch Pharmacol. 2004 Apr.

Abstract

This study characterises the vasorelaxation and hyperpolarisation effects of the negatively charged quaternary compound tetraphenylboron (TPB) in the rat small mesenteric artery. Segments of rat small mesenteric artery were mounted in a myograph and vessel tone and membrane potential were measured simultaneously. In vessels pre-contracted with vasopressin (0.3-0.6 nM), U46619 (30-90 nM) or methoxamine (0.3-3 microM), TPB (0.1-100 microM) produced a marked endothelium-independent relaxation. However, vasorelaxation responses to TPB were abolished in tissues pre-contracted with K(+) (50 mM), and significantly inhibited by glibenclamide (glib, 10 microM). In the absence of tone, TPB (1-30 microM) caused a concentration-dependent membrane hyperpolarisation of rat mesenteric artery smooth muscle cells, which was not dependent on the endothelium, but sensitive to glibenclamide (10 microM). In methoxamine (0.3-3 microM) pre-contracted vessels, the relaxation response was associated with a marked hyperpolarisation, which was also sensitive to glibenclamide (10 microM), further inhibited by a combination of K(+) channel blockers (glib [10 microM], charybdotoxin [100 nM], apamin [100 nM], 4-aminopyridine [1 mM] and Ba(2+) [30 microM]) and abolished by 50 mM K(+). The results of this study show that TPB causes a vasorelaxation and hyperpolarisation response in the rat small mesenteric artery through a direct action on the vascular smooth muscle. TPB exerts its effects partially via the activation of K(ATP) channels, but also by another mechanism involving K(+)-dependent hyperpolarisation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Pharmacol. 1997 Mar 12;322(1):37-44 - PubMed
    1. Biochim Biophys Acta. 1968 Sep 17;163(2):125-36 - PubMed
    1. Br J Pharmacol. 1991 May;103(1):1184-90 - PubMed
    1. Eur J Pharmacol. 1998 Apr 17;347(1):119-23 - PubMed
    1. Clin Exp Pharmacol Physiol. 1992 Dec;19(12):815-25 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources